Low-grade B-cell lymphoma with coexpression of both CD5 and CD10 - A report of 3 cases

被引:0
|
作者
Barekman, CL [1 ]
Aguilera, NSI
Abbondanzo, SL
机构
[1] Walter Reed Army Med Ctr, Dept Pathol, Washington, DC 20307 USA
[2] Walter Reed Army Med Ctr, Dept Hematol, Washington, DC 20307 USA
[3] Armed Forces Inst Pathol, Dept Hematopathol, Washington, DC 20306 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The coexpression of CD5 and CD10 has previously been reported in cases of intermediate- and high-grade lymphomas and in precursor B cells in normal or regenerating bone marrow. We report 3 cases of low-grade B-cell lymphoma that were found to coexpress CD5 and CD10 at the time of initial diagnosis. The first case was classified as small lymphocytic lymphoma; the second as follicle center lymphoma, follicular grade 1; and the third as small B-cell lymphoma otherwise not specified. Currently, the clinical implication of the coexpression of CD5 and CD10 is not known. We describe this finding to highlight the difficulty that may he encountered in classifying lymphomas in cases where this coexpression is present.
引用
收藏
页码:951 / 953
页数:3
相关论文
共 50 条
  • [21] CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen
    Schmieg, John J.
    Muir, Jeannie M.
    Aguilera, Nadine S.
    Auerbach, Aaron
    CURRENT ONCOLOGY, 2021, 28 (06) : 5124 - 5147
  • [22] Management of neurotropic low-grade B-cell lymphoma: Report of two cases
    Garcia-Serra, A
    Mendenhall, NP
    Hinerman, RW
    Lynch, JW
    Braylan, RC
    Mancuso, AA
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (11): : 972 - 976
  • [23] CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis
    Ohshima, K
    Kawasaki, C
    Muta, H
    Muta, K
    Deyev, V
    Haraoka, S
    Suzumiya, J
    Podack, ER
    Kikuchi, M
    HISTOPATHOLOGY, 2001, 39 (02) : 156 - 162
  • [24] CD5, CD10, CD23, and CD25 negative monoclonal small B-cell leukemia: Is this primary marginal zone leukemia?
    Sheikh, SS
    Al-Kuraya, KA
    Kallakury, BVS
    Hartmann, DP
    Bagg, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 562 - 562
  • [25] Bcl-6 Coexpression in Mantle Cell Lymphoma: A Rare Finding Associated with a Lack of CD5 and/or CD3 Coexpression
    Shaw, A. J.
    Gown, A. M.
    Hwang, H. C.
    Kandalaft, P. L.
    Goldstein, L. C.
    Kussick, S. J.
    MODERN PATHOLOGY, 2009, 22 : 286A - 287A
  • [26] Bcl-6 Coexpression in Mantle Cell Lymphoma: A Rare Finding Associated with a Lack of CD5 and/or CD3 Coexpression
    Shaw, A. J.
    Gown, A. M.
    Hwang, H. C.
    Kandalaft, P. L.
    Goldstein, L. C.
    Kussick, S. J.
    LABORATORY INVESTIGATION, 2009, 89 : 286A - 287A
  • [27] A rare case of dual expression of CD5 and CD10 in primary central nervous system diffuse large B-cell lymphoma with prominent starry sky appearance
    McCorkle, Colin
    Graffeo, Vincent
    CLINICAL CASE REPORTS, 2020, 8 (12): : 2972 - 2974
  • [28] BICLONAL LYMPHOPLASMACYTIC LYMPHOMA MIMICKING BENIGN CD5(-)/CD10(-) POLYTYPIC B-CELLS BY FLOW CYTOMETRY. A CASE REPORT
    Idrees, Afshan
    Lancet, Jeffrey E.
    Horna, Pedro
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84 (06) : 412 - 412
  • [29] Clinicopathologic analysis of CD10+and CD10-diffuse large B-cell lymphoma - Identification of a high-risk subset with coexpression of CD10 and bcl-2
    Xu, Y
    McKenna, RW
    Molberg, KH
    Kroft, SH
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (02) : 183 - 190
  • [30] THE UTILITY OF CD20 AND CD43 IN SUBCLASSIFICATION OF LOW-GRADE B-CELL LYMPHOMA ON PARAFFIN SECTIONS
    CONTOS, MJ
    KORNSTEIN, MJ
    INNES, DJ
    BENEZRA, J
    MODERN PATHOLOGY, 1992, 5 (06) : 631 - 633